CR8406A - Forma de administracion del naproxeno sodico - Google Patents

Forma de administracion del naproxeno sodico

Info

Publication number
CR8406A
CR8406A CR8406A CR8406A CR8406A CR 8406 A CR8406 A CR 8406A CR 8406 A CR8406 A CR 8406A CR 8406 A CR8406 A CR 8406A CR 8406 A CR8406 A CR 8406A
Authority
CR
Costa Rica
Prior art keywords
weight
sodium naproxen
tablet core
administration
tablet
Prior art date
Application number
CR8406A
Other languages
English (en)
Spanish (es)
Inventor
Gruber Peter
Siegmund Martin
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34529359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR8406(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Publication of CR8406A publication Critical patent/CR8406A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CR8406A 2003-10-30 2006-05-15 Forma de administracion del naproxeno sodico CR8406A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH18482003 2003-10-30

Publications (1)

Publication Number Publication Date
CR8406A true CR8406A (es) 2008-04-25

Family

ID=34529359

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8406A CR8406A (es) 2003-10-30 2006-05-15 Forma de administracion del naproxeno sodico

Country Status (15)

Country Link
US (1) US20070134317A1 (pt)
EP (1) EP1684728B1 (pt)
JP (1) JP2007509862A (pt)
AR (1) AR046213A1 (pt)
AT (1) ATE442840T1 (pt)
BR (1) BRPI0415624A (pt)
CA (1) CA2543709A1 (pt)
CR (1) CR8406A (pt)
DE (1) DE602004023220D1 (pt)
EC (1) ECSP066587A (pt)
ES (1) ES2333332T3 (pt)
PA (1) PA8616101A1 (pt)
PE (1) PE20050445A1 (pt)
UY (1) UY28583A1 (pt)
WO (1) WO2005041938A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005115345A1 (en) * 2004-05-28 2005-12-08 Imaginot Pty Ltd Oral therapeutic compound delivery system
RU2403033C2 (ru) 2005-03-22 2010-11-10 Лозан Фарма Гмбх Солюбилизированный ибупрофен
EP3263117A1 (en) 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
WO2017062997A1 (en) * 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation
JP7163014B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 感冒薬
JP7163015B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 経口固形組成物
US11779541B2 (en) * 2019-03-26 2023-10-10 Johnson & Johnson Consumer Inc. Immediate release dosage form

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
US5034416A (en) * 1988-01-19 1991-07-23 Smith Walton J Carboxylic acid compositions
US5358717A (en) * 1989-12-22 1994-10-25 Syntex (U.S.A.) Inc. Directly-compressible naproxen or naproxen sodium compositions
PT96229B (pt) * 1989-12-22 1998-06-30 Syntex Pharma Int Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico
IT1272149B (it) * 1993-03-26 1997-06-11 Zambon Spa Composizione farmeceutiche ad attivita' analgesica
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
JPH10298072A (ja) * 1997-04-17 1998-11-10 Panacea Biotec Ltd 非ステロイド性抗炎症剤の遷移金属錯体
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
US6165506A (en) * 1998-09-04 2000-12-26 Elan Pharma International Ltd. Solid dose form of nanoparticulate naproxen
US6383515B2 (en) * 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
WO2002083110A2 (en) * 2001-04-10 2002-10-24 Zagros Pharma, Inc. Animal model for evaluating analgesics
US20030008003A1 (en) * 2001-04-10 2003-01-09 Fahkreddin Jamali Compositions for enhanced absorption of NSAIDs

Also Published As

Publication number Publication date
BRPI0415624A (pt) 2006-12-12
WO2005041938A1 (en) 2005-05-12
US20070134317A1 (en) 2007-06-14
UY28583A1 (es) 2005-05-31
ATE442840T1 (de) 2009-10-15
AR046213A1 (es) 2005-11-30
JP2007509862A (ja) 2007-04-19
PA8616101A1 (es) 2005-08-04
ECSP066587A (es) 2006-10-17
EP1684728A1 (en) 2006-08-02
PE20050445A1 (es) 2005-06-18
CA2543709A1 (en) 2005-05-12
EP1684728B1 (en) 2009-09-16
DE602004023220D1 (de) 2009-10-29
ES2333332T3 (es) 2010-02-19

Similar Documents

Publication Publication Date Title
CO6501159A2 (es) Formulaciones farmaceuticas de liberación controlada de nitazoxanida
UY26496A1 (es) Composiciones farmacéuticas que proporcionan concentraciones potenciadas de fármaco
AR097045A2 (es) Sistema terapéutico transdérmico
EA200700340A1 (ru) Мультичастицы
CL2008002407A1 (es) Forma de dosificacion oral que comprende al menos un agente activo de nicotina, al menos un material bioadhesivo capaz de formar un enlace de hidrogeno con el agente activo de nicotina, y al menos un agente de impacto sensorial que se libere rapidamente; y su uso para proporcionar alivio rapido de las ansias de nicotina (div. sol. 1825-04).
BRPI0513847A (pt) formulação de comprimido de liberação extendida contendo pramipexol ou um sal farmaceuticamente aceitável do mesmo, método para a fabricação do mesmo e uso do mesmo
CY1111800T1 (el) Συνδυασμοι δραστικων ουσιων με νηματοδοκτονες, εντομοκτονες και μυκητοκτονες ιδιοτητες με βαση τριφθοροβουτενυλικες ενωσεις
CR11581A (es) Composiciones en forma de comprimidos bucodispersables de temazepan
BRPI0413361B8 (pt) comprimido seguro contra abuso termo-moldado por extrusão sem descoramento
CR20110188A (es) Combinacion de una insulina y un agonista de glp-1
MX2019012657A (es) Inhibidores de tirosina cinasa de bruton.
AR041428A1 (es) Forma de dosificacion de ibuprofeno sodico
CY1109152T1 (el) Διαταξη παροχης φαρμακου
CR10172A (es) Uso de derivados de sulfamida heterociclica benzo-fusionada para el tratamiento de abuso y adicción de sustancias
EA200400866A1 (ru) Ламинированный инсектицидный диспенсер
CR8406A (es) Forma de administracion del naproxeno sodico
GT200600200A (es) Composicion farmaceutica que contienen gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato
BRPI0418378A (pt) combinações de substáncias ativas com propriedades inseticidas
MX2018013729A (es) Forma cristalina nueva de dapagliflozina y metodo de preparacion y uso de la misma.
UY27220A1 (es) Combinación de un taxano con una quinasa ciclina-dependiente
AR064344A1 (es) Metodo para mejorar la apariencia corporal utilizando dosis bajas y aumento escalonado de la dosis
GT200500315A (es) Formas de dosificacion oral solidas que contienen una dosis baja de estradiol
FI20055057A7 (fi) Puolijohdelaite
BRPI0513257A (pt) composição farmacêutica lìquida
AR048958A1 (es) Medicamento en forma de pelicula para administracion por via oral, que contiene estriol

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)